ATE552002T1 - Feste zubereitung zur oralen verabreichung - Google Patents

Feste zubereitung zur oralen verabreichung

Info

Publication number
ATE552002T1
ATE552002T1 AT09712557T AT09712557T ATE552002T1 AT E552002 T1 ATE552002 T1 AT E552002T1 AT 09712557 T AT09712557 T AT 09712557T AT 09712557 T AT09712557 T AT 09712557T AT E552002 T1 ATE552002 T1 AT E552002T1
Authority
AT
Austria
Prior art keywords
oral administration
solid preparation
cariprazine hydrochloride
lactose
enables
Prior art date
Application number
AT09712557T
Other languages
English (en)
Inventor
Yasuaki Oobayashi
Akiko Ookawa
Atsuko Hadama
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of ATE552002T1 publication Critical patent/ATE552002T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT09712557T 2008-02-21 2009-02-20 Feste zubereitung zur oralen verabreichung ATE552002T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008040696 2008-02-21
JP2008284685 2008-11-05
PCT/JP2009/053039 WO2009104739A1 (ja) 2008-02-21 2009-02-20 経口投与用固形製剤

Publications (1)

Publication Number Publication Date
ATE552002T1 true ATE552002T1 (de) 2012-04-15

Family

ID=40985616

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09712557T ATE552002T1 (de) 2008-02-21 2009-02-20 Feste zubereitung zur oralen verabreichung

Country Status (9)

Country Link
US (1) US20110059980A1 (de)
EP (1) EP2251011B1 (de)
JP (2) JP4409630B2 (de)
KR (2) KR101563383B1 (de)
CN (1) CN102014909B (de)
AT (1) ATE552002T1 (de)
CA (1) CA2715760C (de)
EA (1) EA023972B1 (de)
WO (1) WO2009104739A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
ATE552002T1 (de) * 2008-02-21 2012-04-15 Richter Gedeon Nyrt Feste zubereitung zur oralen verabreichung
JP5774988B2 (ja) * 2008-07-16 2015-09-09 リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ ドーパミン受容体リガンドからなる製剤処方
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
CN106560179B (zh) * 2015-09-30 2020-02-21 石药集团中奇制药技术(石家庄)有限公司 盐酸卡利拉嗪药物组合物及其制备方法
EP3231418A1 (de) * 2016-04-14 2017-10-18 Richter Gedeon Nyrt. Granulatformulierung zur oralen verabreichung
CN109414051A (zh) * 2016-06-28 2019-03-01 株式会社日本抗菌总和研究所 赋形剂和片剂
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
CN107970217A (zh) * 2016-10-25 2018-05-01 浙江京新药业股份有限公司 卡利拉嗪口腔崩解片及其制备方法
CN108261394B (zh) * 2017-01-04 2022-03-04 广东东阳光药业有限公司 一种盐酸卡利拉嗪注射制剂及其制备方法和用途
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
US11273156B2 (en) * 2018-11-20 2022-03-15 Aurobindo Pharma Ltd Stable cariprazine formulations for oral use
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
US11344503B2 (en) * 2019-12-13 2022-05-31 Halo Science LLC Cariprazine release formulations
CA3187349A1 (en) * 2020-08-06 2022-02-10 Ji Hye Lee Solid oral composition comprising carbamate compound, and preparation method therefor

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666911A (en) * 1981-07-14 1987-05-19 Taiho Pharmaceutical Company Limited Allophanoylpiperazine compound and analgesic composition containing same as active ingredient
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
US4957921A (en) * 1989-12-06 1990-09-18 Warner-Lambert Company Substituted cyclohexanols as central nervous system agents
JP3696884B2 (ja) * 1994-03-25 2005-09-21 アイソテクニカ、インコーポレーテッド ジュウテリウム化による薬物の効能の増強
US6334997B1 (en) * 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6528529B1 (en) * 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
KR20010053010A (ko) * 1998-06-30 2001-06-25 이베 사치아키 엔-페닐-엔'-페닐프로필피페라진 유도체 및 그의제조방법
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
KR20030074849A (ko) * 2001-02-27 2003-09-19 오르토-맥네일 파마슈티칼, 인코퍼레이티드 양극성 장애의 예방 또는 치료에 사용하기 위한카바메이트 화합물
US6566550B2 (en) * 2001-06-21 2003-05-20 Pfizer Inc Substituted aromatic ethers as inhibitors of glycine transport
HU227543B1 (en) * 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them
US6919342B2 (en) * 2003-06-05 2005-07-19 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
DE102004047517A1 (de) * 2004-09-28 2006-03-30 Merck Patent Gmbh Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid
HU230748B1 (hu) * 2007-05-11 2018-02-28 Richter Gedeon Nyrt Új piperazin só és előállítási eljárása
EP2155200B1 (de) * 2007-05-11 2016-12-07 Richter Gedeon Nyrt. Kristalline form eines carbamoyl-cyclohexan-derivats
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
HUP0700369A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia
JP2011513196A (ja) * 2007-08-01 2011-04-28 ハー・ルンドベック・アクチエゼルスカベット ドーパミン作動系が破壊された障害もしくは状態の症状を軽減するためまたはその障害もしくは状態を処置するためのkcnqカリウムチャネル開口薬の使用
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
ATE552002T1 (de) * 2008-02-21 2012-04-15 Richter Gedeon Nyrt Feste zubereitung zur oralen verabreichung
JP5774988B2 (ja) * 2008-07-16 2015-09-09 リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ ドーパミン受容体リガンドからなる製剤処方
HU230067B1 (hu) * 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800766A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
HUP0800765A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts

Also Published As

Publication number Publication date
CN102014909A (zh) 2011-04-13
KR20100117676A (ko) 2010-11-03
EP2251011A1 (de) 2010-11-17
US20110059980A1 (en) 2011-03-10
JP4409630B2 (ja) 2010-02-03
EA023972B1 (ru) 2016-08-31
CN102014909B (zh) 2013-03-13
KR101563383B1 (ko) 2015-10-26
EP2251011A4 (de) 2011-03-02
WO2009104739A1 (ja) 2009-08-27
CA2715760A1 (en) 2009-08-27
JPWO2009104739A1 (ja) 2011-06-23
KR20130115393A (ko) 2013-10-21
EP2251011B1 (de) 2012-04-04
EA201001334A1 (ru) 2011-06-30
CA2715760C (en) 2017-06-13
JP2010132654A (ja) 2010-06-17

Similar Documents

Publication Publication Date Title
ATE552002T1 (de) Feste zubereitung zur oralen verabreichung
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
CR20110110A (es) Composicion farmaceutica
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
EA201170512A1 (ru) Композиция для перорального введения
BRPI0906020A2 (pt) Sais farmaceuticamente aceitáveis de 2-{4-[ (3s) - piperidina-3-il ] fenil} -2h - indazol - 7 - carboxamida, uso e método de tratamento
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
EA201290116A1 (ru) Новые композиции 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
NO20075111L (no) Farmasoytisk sammensetning
WO2009149056A3 (en) Combinations of niacin and an oxicam
ZA201100615B (en) Appetising medicament for oral administration in solid form
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
DK2018158T3 (da) Ny racecadotril administrationsform
BR112015002183A2 (pt) processos para a preparação de (s) -3- (4 - ((4- (morfolinometil) benzil) oxi) -1-oxoisoindolin-2-il) -piperidina-2,6-diona e formas farmaceuticamente aceitáveis da mesma
WO2010055119A3 (en) Pharmaceutical composition comprising pimobendan
UA97660C2 (ru) Жидкие композиции солей 4-[2-(4-метилфенилсульфанил)фенил]-пиперидина
MX2010003989A (es) Composicion zibotentan que contiene mannitol y/o celulosa microcristalina.
EP2062579A4 (de) Feste pharmazeutische zusammensetzung zur oralen verabreichung mit optisch stabilem ramosetron
BRPI0918539A2 (pt) preparação farmacêutica sólida para administração oral
CY1119315T1 (el) Στερεες μορφες που περιεχουν μελοξικαμη με βελτιωμενη στοματικη γευση και η διαδικασια για τηn προετοιμασια τους
DE602008002371D1 (de) Pharmazeutische zusammensetzung mit candesartan-cilexetil
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
BRPI0919194A2 (pt) preparação sólida para administração oral